Gerresheimer at CPhI Worldwide: global presence for innovative and sustainable solutions for biotech and pharma

The compatibility of innovation, solution and sustainability are at the top of Gerresheimer's agenda. The internationally active and globally producing company also demonstrates this at CPhI Worldwide with its new developments for primary packaging, drug delivery systems and medical and diagnostic products.
(PresseBox) ( Düsseldorf, Germany, )
Gerresheimer's global presence in Europe, America and Asia at numerous certified own production sites enables regional and market-oriented cooperation and logistics with partners in the pharma world. At CPhI Worldwide in Milano the company will be presenting its innovative, solution-oriented and sustainable developments. The wide range of products includes solutions, products and delivery systems for drugs, vaccines or high potency biologics.

The compatibility of innovation, solution and sustainability are at the top of Gerresheimer's agenda. The internationally active and globally producing company also demonstrates this at CPhI Worldwide with its new developments for primary packaging, drug delivery systems and medical and diagnostic products. In addition, Gerresheimer specializes in the development of packaging and delivery solutions for newly developed biologics.

CphI Worldwide takes place on November 09 up to 11 in Milano (Italy) at the Fiera Milano. The Gerresheimer team is expecting its visitors in Hall 6 at booth J10. Here are some product highlights:

SensAIR, the platform for an innovative on-body drug delivery device for drugs with higher viscosity

With SensAIR Gerresheimer presents for the first time an innovative platform for an on-body drug delivery device for drugs with higher viscosity, such as monoclonal antibodies (mAb). The aim is to offer patients the best possible support in the subcutaneous delivery of large-volume biologics. The device can be adapted to many drugs of different viscosity and different requirements. Together with Gerresheimer's One-Stop-Shop quality promise, which comprises a solution from cartridge to drug delivery device from a single source, SensAIR enables the safe and optimized delivery of biologics.

Gx InnoSafe protects against unintentional needlestick injuries and is easy to fill

Nurses are among the occupational groups with the most frequent cuts and puncture wounds. This can lead to infection with dangerous pathogens such as hepatitis B and C viruses or HIV. The Gx InnoSafe safety syringe is the first syringe on the market with a passive needle protection system. Its function prevents anyone from accidentally injuring themselves through an unintentional needle stick on a syringe that has already been used, as the needle is fixed in a sleeve after use. In addition to these unique safety features, a special feature of the Gx InnoSafe syringe is that it can be processed on all existing filling lines without any additional preparation or conversion steps. Furthermore, it complies with all regulations without any additional investment.

Gx RTF Vials - The solution for clinical trials and industrialization: Depyrogenated, sterile and ready-to-use vials for injectables of highest quality

The Gx RTF injection vials are made of borosilicate glass type I and meet all common requirements of the applicable ISO standards and pharmacopoeias (USP and Ph. Eur.). They are formed in accordance with cGMP, washed in a clean room, packed in trays or nests and tubs and sterilized. Gerresheimer RTF vials are also supplied in the familiar Ompi EZ-fill packaging format. This means they are ready for the next process steps in filling.

Injection and infusion bottles made of type II glass: the solution for parenteral applications

Gerresheimer also specializes in the production of pharmaceutical containers made of Type II glass. Both the smallest bottle sizes for injections and typical infusion bottles with larger volumes can be treated with a special tempering method. Ensuring the glass quality and the hydrolytic resistance of the type II glass are the top priorities here. The new furnace technology, the expansion of the clean room, and the automation and digitalization of the testing and packaging facilities have enabled the company to secure its leading position.

EcoLine for the sustainable development of plastic containers

With EcoLine, Gerresheimer demonstrates criteria in the development and production of its well-known plastic container series for solid and liquid medications which play an important role in the design of sustainable packaging solutions and thus contribute to greater environmental compatibility. The concept includes the criteria of weight, volume, material, and recyclability. EcoLine can be applied to the development of all existing Gerresheimer product families such as Duma, Triveni, the dropper bottles and to PET bottles.

Product information at the stand for sustainable download

Gerresheimer is serious about sustainability and this year for the first time will offer its information at the stand for direct download via URL codes instead of printed catalogs and brochures.

Further information about Gerresheimer products on the Internet:

Drug Delivery Systems

Download information about drug delivery systems

Medical and diagnostic products

Download information about diagnostics and medical services

Pharmaceutical primary packaging and syringes

Download information about pharmaceutical primary packaging
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.